Transcatheter arterial chemoembolization as an examination method for hepatocellular carcinoma undetected by B‑mode ultrasound, computed tomography and digital subtratcion angiography: A case report

Xu,Zongquan; Yu,Chen; Wang,Shufang; Xu,Guohui

doi:10.3892/ol.2015.3446

Transcatheter arterial chemoembolization as an examination method for hepatocellular carcinoma undetected by B‑mode ultrasound, computed tomography and digital subtratcion angiography: A case report

Authors:
- Zongquan Xu
- Chen Yu
- Shufang Wang
- Guohui Xu
View Affiliations

Affiliations: Department of Hepatic Oncology, Jiangxi Province Cancer Hospital, Nanchang, Jiangxi 330029, P.R. China, Department of Bone Oncology, Jiangxi Province Cancer Hospital, Nanchang, Jiangxi 330029, P.R. China
Published online on: July 1, 2015 https://doi.org/10.3892/ol.2015.3446
Pages: 1759-1762

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Transcatheter arterial chemoembolization (TACE) is the conventional treatment for patients with unresectable hepatocellular carcinoma (HCC), but few studies to date have demonstrated the use of TACE as an examination method for uneasily detected HCC. The present study describes an unusual case of HCC with TACE as an examination method. A 41‑year‑old male presented with an elevated α‑fetoprotein level (AFP) of 3,635 ng/ml, however, no tumor lesions were detected by B‑mode ultrasound, computed tomography (CT) or digital subtraction angiography. During TACE treatment, two tumor lesions of ~0.5 and 0.8 cm were revealed in the right liver lobe, with no tumors in the left liver lobe. A month after TACE, a liver CT scan found 11 lesions (8 in the right liver lobe and 3 in the left liver lobe). The HCC patient's AFP levels decreased to an almost normal level following the TACE treatment. This study provokes consideration of the application of TACE in the diagnosis and treatment of HCC patients with liver lesions that are hard to detect by conventional means.

View Figures

View References

1	Villanueva A, Minguez B, Forner A, Reig M and Llovet JM: Hepatocellular carcinoma: Novel molecular approaches for diagnosis, prognosis, and therapy. Annu Rev Med. 61:317–328. 2010. View Article : Google Scholar : PubMed/NCBI
2	Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
3	Meyers WC: Neoplasms of the liverTextbook of Surgery: The Biological Basis of Modern Surgical Practice. Sabiston DC Jr: 1. 15th. W.B. Saunders Co.; Philadelphia: pp. 1069–1072. 1999
4	Bruix J and Sherman MAmerican Association for the Study of Liver Diseases: Management of hepatocellular carcinoma: An update. Hepatology. 53:1020–1022. 2011. View Article : Google Scholar : PubMed/NCBI
5	European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer, . EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
6	Lencioni R, Chen XP, Dagher L and Venook AP: Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: How can outcomes be improved? Oncologist. 15 (Suppl 4):S42–S52. 2010. View Article : Google Scholar
7	Yamashita T and Kaneko S: Treatment strategies for hepatocellular carcinoma in Japan. Hepatol Res. 43:44–50. 2013. View Article : Google Scholar : PubMed/NCBI
8	Llovet JM, Brú C and Bruix J: Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis. 19:329–338. 1999. View Article : Google Scholar : PubMed/NCBI
9	Ikai I, Kudo M, Arii S, et al: Report of the 18^th follow-up survey of primary liver cancer in Japan. Hepatol Res. 40:1043–1059. 2010. View Article : Google Scholar
10	Cucchetti A, Ercolani G, Vivarelli M, et al: Is portal hypertension a contraindication to hepatic resection? Ann Surg. 250:922–928. 2009. View Article : Google Scholar : PubMed/NCBI
11	Mazzaferro V, Regalia E, Doci R, et al: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 334:693–699. 1996. View Article : Google Scholar : PubMed/NCBI
12	Mazzaferro V: Results of liver transplantation: With or without Milan criteria? Liver Transpl. 13 (11 Suppl 2):S44–S47. –2007. View Article : Google Scholar : PubMed/NCBI
13	Mazzaferro V, Bhoori S, Sposito C, et al: Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience. Liver Transpl. 17 (Suppl 2):S44–S57. 2011. View Article : Google Scholar : PubMed/NCBI
14	Nishikawa H, Kimura T, Kita R and Osaki Y: Radiofrequency ablation for hepatocellular carcinoma. Int J Hyperthermia. 29:558–568. 2013. View Article : Google Scholar : PubMed/NCBI
15	Lammer J, Malagari K, Vogl T, et al: Role: PRECISION V InvestigatorsProspective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: Results of the PRECISION V study. Cardiovasc Intervent Radiol. 33:41–52. 2010. View Article : Google Scholar : PubMed/NCBI
16	Nicolini D, Svegliati-Baroni G, Candelari R, et al: Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation. World J Gastroenterol. 19:5622–5632. 2013. View Article : Google Scholar : PubMed/NCBI
17	Feng K, Yan J, Li X, et al: A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol. 57:794–802. 2012. View Article : Google Scholar : PubMed/NCBI
18	Orlando A, Leandro G, Olivo M, et al: Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: Meta-analysis of randomized controlled trials. Am J Gastroenterol. 104:514–524. 2009. View Article : Google Scholar : PubMed/NCBI
19	Cho YK, Kim JK, Kim MY, et al: Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology. 49:453–459. 2009. View Article : Google Scholar : PubMed/NCBI
20	Shen A, Zhang H, Tang C, et al: Systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm. J Gastroenterol Hepatol. 28:793–800. 2013. View Article : Google Scholar : PubMed/NCBI
21	Takayasu K, Arii S, Kudo M, et al: Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines. J Hepatol. 56:886–892. 2012. View Article : Google Scholar : PubMed/NCBI
22	Takayasu K: Chemoembolization for unresectable hepatocellular carcinoma in Japan. Oncology. 78 (Suppl 1):S135–S141. 2010. View Article : Google Scholar
23	Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D and Burroughs AK: Systematic review: The model for end-stage liver disease - should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther. 22:1079–1089. 2005. View Article : Google Scholar : PubMed/NCBI
24	Bieze M, Klümpen HJ, Verheij J, et al: Diagnostic accuracy of (18) F-methylcholine positron emission tomography/computed tomography for intra- and extrahepatic hepatocellular carcinoma. Hepatology. 59:996–1006. 2014. View Article : Google Scholar : PubMed/NCBI
25	Tenley N, Corn DJ, Yuan L and Lee Z: The effect of fasting on PET imaging of hepatocellular carcinoma. J Cancer Ther. 4:561–567. 2013. View Article : Google Scholar : PubMed/NCBI
26	Yu NC, Chaudhari V, Raman SS, et al: CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol Hepatol. 9:161–167. 2011. View Article : Google Scholar : PubMed/NCBI
27	Li JJ, Zheng JS, Cui SC, et al: C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma. World J Gastroenterol. 21:3035–3040. 2015. View Article : Google Scholar : PubMed/NCBI
28	Tognolini A, Louie JD, Hwang GL, et al: Utility of C-arm CT in patients with hepatocellular carcinoma undergoing transhepatic arterial chemoembolization. J Vasc Interv Radiol. 21:339–347. 2010. View Article : Google Scholar : PubMed/NCBI
29	Kim MJ, Kim YS, Cho YH, et al: Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization. Korean J Intern Med. 30:308–315. 2015. View Article : Google Scholar : PubMed/NCBI
30	Cho Y, Lee DH, Lee YB, et al: Does 18F-FDG positron emission tomography-computed tomography have a role in initial staging of hepatocellular carcinoma? PLoS One. 9:e105679–2014. View Article : Google Scholar : PubMed/NCBI
31	Zheng J, Li J, Cui X, Ye H and Ye L: Comparison of diagnostic sensitivity of C-arm CT, DSA and CT in detecting small HCC. Hepatogastroenterology. 60:1509–1512. 2013.PubMed/NCBI
32	Bartolozzi C, Lencioni R, Caramella D, Palla A, Bassi AM and Di Candio G: Small hepatocellular carcinoma. Detection with US, CT, MR imaging, DSA, and Lipiodal-CT. Acta Radio. 37:69–74. 1996. View Article : Google Scholar
33	Peng ZW, Zhang YJ, Chen MS, et al: Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: A prospective randomized trial. J Clin Oncol. 31:426–432. 2013. View Article : Google Scholar : PubMed/NCBI
34	Yang HJ, Lee JH, Lee DH, et al: Small single-nodule hepatocellular carcinoma: Comparison of transarterial chemoembolization, radiofrequency ablation, and hepatic resection by using inverse probability weighting. Radiology. 271:909–918. 2014. View Article : Google Scholar : PubMed/NCBI
35	Scheuermann U, Kaths JM, Heise M, et al: Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma - a single-center experience. Eur J Surg Oncol. 39:593–600. 2013. View Article : Google Scholar : PubMed/NCBI
36	Liao M, Huang J, Zhang T and Wu H: Transarterial chemoembolization in combination with local therapies for hepatocellular carcinoma: A meta-analysis. PLoS One. 8:e684532013. View Article : Google Scholar : PubMed/NCBI
37	Salhab M and Canelo R: An overview of evidence-based management of hepatocellular carcinoma: A meta-analysis. J Cancer Res Ther. 7:463–475. 2011. View Article : Google Scholar : PubMed/NCBI
38	Lin ZZ, Shau WY, Hsu C, et al: Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size. PLoS One. 8:e802762013. View Article : Google Scholar : PubMed/NCBI